Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101

ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon

BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer

Galibra Neuroscience's SSADH deficiency gene therapy receives FDA Orphan Drug and Rare Pediatric Disease Designations

Obsidian Therapeutics advances Agni-01 study with first patient enrolled in registration-enabling cohort

CVS Health expands GLP-1 weight management access through integrated care offering

Adyen to provide LillyDirect with payment technology services

Sanofi's MenQuadfi receives EU approval for infants from six weeks

Acurx receives FDA guidance supporting ibezapolstat Phase 3 development strategy

Zai Lab's zoci receives FDA orphan designation for neuroendocrine carcinomas

Biocon launches Yesafili biosimilar in US ophthalmology market

Ractigen Therapeutics IND application for RAG-1C receives FDA clearance

Pfizer reports positive Phase 3 results for LITFULO in nonsegmental vitiligo

European Commission approves RINVOQ for severe alopecia areata

Incyte's Opzelura approved in European Union for moderate atopic dermatitis